Natural Health Trends Corp. — Q1 2013 Form 10-Q
Reporting period: Three months ended March 31, 2013. Financial statement amounts are in thousands of U.S. dollars except per-share data. Natural Health Trends sells personal care, wellness and “quality of life” products under the NHT Global brand through an international direct-selling and e-commerce business. It reported approximately 20,400 active distributors and one operating segment.
Financial performance and position
| Metric | Q1 2013 | Q1 2012 |
|---|---|---|
| Net sales | $8,651 | $9,090 |
| Gross profit / margin | $6,423 / 74.2% | $6,691 / 73.6% |
| Operating income / margin | $292 / 3.3% | $551 / 6.1% |
| Net income | $287 | $507 |
| Net income available to common stockholders | $283 | $503 |
| Basic / diluted EPS | $0.03 / $0.03 | $0.05 / $0.04 |
| Operating cash flow | $1,018 | $860 |
- Sales declined $439,000, or 5%; gross margin improved 0.6 percentage points, while operating margin fell 2.8 points and net income declined about 43%.
- Distributor commissions were $3.674 million, or 42.5% of sales, versus 40.6% a year earlier. SG&A was essentially flat at $2.445 million.
- Cash and cash equivalents were $5.173 million at quarter-end, up $966,000 from December 31, 2012. Current assets were $6.646 million and current liabilities $6.832 million: a 0.97 current ratio and $186,000 working-capital deficit. Excluding $1.136 million deferred revenue, the current ratio was 1.17.
- Operating cash flow was $1.018 million, primarily reflecting more timely collections from the Russian third-party service provider. Investing cash use was $14,000 and financing cash use was $12,000, including share repurchases. No borrowings are shown on the balance sheet.
- Total assets were $9.019 million and stockholders’ equity $2.187 million at March 31, 2013. Restricted cash was $231,000; goodwill was $1.764 million.
Drivers, outlook and risks
- Hong Kong generated $6.048 million, or 69.9% of quarterly sales; management said approximately 94% of sales came from subsidiaries outside North America. Russia sales fell 28%, partly because the prior-year period benefited from an incentive-trip qualification deadline. North America sales rose 22% and Taiwan sales rose 20%.
- Management attributed higher gross margin to lower Russian third-party service-provider fees and lower import costs as a share of sales. Commission expense rose as a share of sales due to higher commission rates in Russia and additional incentive-program costs.
- Management believed cash on hand and operating cash flows would fund normal operations and commitments for at least the next 12 months, assuming no significant unforeseen expense or revenue decline. It did not expect to need capital-market funding, but noted it had no significant unused liquid-asset sources.
- The company planned to focus resources on Greater China and selected CIS markets, including Russia, Ukraine and Kazakhstan, and did not intend to devote material resources to opening additional foreign markets. It provided no specific revenue or earnings guidance.
- China is a material concentration and regulatory exposure: the company lacked a direct-selling license, and its application had not materially progressed. Hong Kong sales largely serve members in China; management cautioned that Chinese authorities could reinterpret or change rules affecting the e-commerce business. Enforcement uncertainty and distributor activity also could affect participation.
- Other disclosed risks include foreign-exchange movements, reliance on distributors and third-party manufacturers, direct-selling and product regulation, competition, product acceptance, and potential cash-flow deterioration. Foreign-currency translation reduced comprehensive income by $28,000 in Q1 2013; foreign-exchange income was $7,000 versus a $63,000 net expense in Q1 2012.
- A related-party license with a director’s company provides rights to manufacture and sell Restor for a 2.5% sales royalty. The company paid $37,000 for 2011–2012 royalties and accrued approximately $7,000 for Q1 2013. A similar Soothe agreement was under discussion; estimated royalties for 2012 and Q1 2013 were approximately $2,400.
- For South Korean consumer-indemnity obligations, the maximum potential payments under the contract are tied to three months of rolling sales; $91,000 of restricted underlying assets was held at quarter-end. Management considered use of those funds remote. No registration-payment liability was recognized.
Important facts to verify
- Whether Hong Kong/China sales concentration, Chinese regulatory developments, and Russia’s sales trajectory have changed since the filing.
- Whether cash generation and liquidity remain adequate given the working-capital deficit and management’s assumptions about revenue and expenses.
- The effect of distributor commissions and incentive programs on margins, and whether sales comparisons are affected by differing promotion schedules.
- The status and final terms of the proposed Soothe related-party royalty arrangement and ongoing Restor royalty accruals.
- Warrant dilution and expiration details: 3,704,854 warrants were reported outstanding at March 31, 2013; certain warrants expired unexercised in April and May 2013. The filing does not clearly state the remaining warrant count after those expirations.